Feasibility of a randomized single-blind crossover trial to assess the effects of the second-generation slow-release dopamine agonists pramipexole and ropinirole on cued recall memory in idiopathic mild or moderate Parkinson’s disease without cognitive impairment

BACKGROUND: The aim was to assess the feasibility of a single-centre, single-blind, randomized, crossover design to explore the effects of two slow-release dopamine agonists, ropinirole and pramipexole, on cued recall in Parkinson’s disease. As the design required a switch from the prescribed agonis...

Descripción completa

Detalles Bibliográficos
Autores principales: Shepherd, Thomas A., Edelstyn, Nicola M. J., Longshaw, Laura, Sim, Julius, Watts, Keira, Mayes, Andrew R., Murray, Michael, Ellis, Simon J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501424/
https://www.ncbi.nlm.nih.gov/pubmed/28694990
http://dx.doi.org/10.1186/s40814-017-0154-7

Ejemplares similares

Ejemplares similares